Mobile drug testing is not a side business. It is a regulated professional field operating within a federal compliance framework administered by the U.S. Department of Transportation (DOT), the Department of Health and Human Services (HHS), and a network of agency-specific regulations that govern everything from specimen collection protocols to chain of custody documentation.
The Federal Motor Carrier Safety Administration (FMCSA), the Federal Aviation Administration (FAA), the Federal Railroad Administration (FRA), the Federal Transit Administration (FTA), and the Pipeline and Hazardous Materials Safety Administration (PHMSA) each mandate drug and alcohol testing programs for employees in safety-sensitive positions. The collectors who service those programs operate under 49 CFR Part 40 — a detailed regulatory framework that specifies collector qualifications, collection site requirements, chain of custody procedures, and specimen handling standards.
This guide covers what mobile drug testing professionals do, the regulatory environment in which they operate, the specific steps required to enter the profession, available certifications, day-to-day practice, and the income and business structure of a mobile collection practice.
What Is a Mobile Drug Testing Professional?
A mobile drug testing professional is a trained and qualified urine specimen collector — and often a Breath Alcohol Technician (BAT) — who travels to client locations to conduct federally regulated drug and alcohol tests. Unlike fixed-site collection facilities such as urgent care clinics or occupational health centers, a mobile collector operates as a service that comes to the employer, worksite, or facility.
The role may also involve support functions adjacent to the Medical Review Officer (MRO) process, including documentation preparation, specimen tracking, and coordination of test results reporting through the MRO to the employer.
Primary client settings include:
- DOT-regulated motor carriers (trucking and transportation companies subject to FMCSA regulations)
- Commercial aviation operators regulated by the FAA
- Railroad and transit operations regulated by the FRA and FTA
- Pipeline and hazardous materials employers regulated by PHMSA
- Construction and manufacturing companies with non-DOT employer programs
- Healthcare facilities, government agencies, and staffing firms
Types of testing conducted by mobile collectors span the full federally mandated testing menu:
- Pre-employment — prior to placing an employee in a safety-sensitive function
- Random — conducted on a scientifically random basis throughout the calendar year
- Reasonable suspicion — based on specific, contemporaneous observations by a trained supervisor
- Post-accident — following a qualifying accident or incident as defined by agency regulations
- Return-to-duty — required before an employee who tested positive or refused testing resumes safety-sensitive duties
- Follow-up — unannounced follow-up testing required after return-to-duty, typically over a 12-month period
The mobile model is distinct from fixed-site collection in one critical respect: the collector is responsible for establishing a temporary collection site that meets all federal requirements at each client location, without the infrastructure of a permanent facility.
Regulatory Framework
49 CFR Part 40 — The Governing Standard
All DOT-mandated drug and alcohol testing — regardless of which modal agency's program applies — is governed by 49 CFR Part 40 (Procedures for Transportation Workplace Drug and Alcohol Testing Programs). Part 40 is administered by the Office of Drug and Alcohol Policy and Compliance (ODAPC) within the U.S. Department of Transportation.
Part 40 establishes uniform procedures across all DOT agencies for collector qualifications, collection site requirements, the Federal Drug Testing Custody and Control Form (CCF), specimen handling, laboratory requirements, MRO responsibilities, and SAP (Substance Abuse Professional) functions. No DOT-regulated testing program may deviate from Part 40's procedures.
Agency-Specific Regulations
Each DOT modal agency has its own regulation that applies Part 40 procedures to its specific regulated industries:
- FMCSA — 49 CFR Part 382: Governs drug and alcohol testing for commercial motor vehicle (CMV) operators subject to federal hours-of-service requirements. Motor carriers employing CDL drivers are required to maintain testing programs that meet both Part 40 and Part 382 requirements.
- FAA — 14 CFR Part 120: Governs drug and alcohol testing programs for aviation employees performing safety-sensitive functions, including flight crew, maintenance personnel, and air traffic controllers.
- FRA — 49 CFR Part 219: Governs railroad employees covered by the Federal Railroad Safety Act.
- FTA — 49 CFR Part 655: Governs public transportation employees in safety-sensitive positions receiving federal transit assistance.
- PHMSA — 49 CFR Part 199: Governs pipeline industry employees performing operations, maintenance, or emergency response functions.
Non-DOT Testing Programs
Not all employer drug testing programs are DOT-mandated. Many employers — including construction companies, healthcare organizations, retailers, and government contractors — maintain their own drug-free workplace programs designed to satisfy state workers' compensation program requirements, insurance carrier mandates, or contractual obligations. These non-DOT programs are not subject to Part 40 procedures, though many employers voluntarily adopt Part 40 standards as a framework.
Mobile collectors working both DOT and non-DOT testing must clearly document which standard applies to each collection, as the CCF is specific to DOT-regulated testing and should not be used for non-DOT collections.
Chain of Custody and Federal Documentation
The Federal Drug Testing Custody and Control Form (CCF) is the standardized, five-part federal document that accompanies every DOT-regulated specimen from collection through laboratory analysis. The CCF documents the donor's identity, the collector's certification, specimen seal integrity, and the laboratory's analysis record. Proper CCF completion and management is one of the most technically detailed requirements under Part 40 — errors in CCF documentation are a primary source of fatal flaws that may require recollection.
HHS Mandatory Guidelines and SAMHSA-Certified Laboratories
The HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs establish the scientific and technical standards that federal agency and DOT-regulated testing programs must follow. Under these Guidelines, specimens collected for DOT-regulated testing must be analyzed exclusively at laboratories that hold a current HHS certification — commonly referred to as SAMHSA-certified laboratories (Substance Abuse and Mental Health Services Administration). A current list of certified laboratories is published on the SAMHSA website.
The MRO Relationship
The Medical Review Officer (MRO) is a licensed physician who receives, reviews, and interprets laboratory results for DOT-regulated drug tests. The MRO's role is to determine whether a verified positive, adulterated, substituted, or invalid result has a legitimate medical explanation before the result is reported to the employer. The collector's relationship to the MRO is primarily documentary — the collector's accurate CCF completion ensures the MRO has the information necessary to perform the final determination. Collectors do not interpret results and do not communicate test outcomes to employers.
Step-by-Step: How to Become a Mobile Drug Testing Professional
Step 1: Understand the Regulatory Landscape
Before completing any training, practitioners entering this field must understand the distinction between DOT and non-DOT testing — and which agency's regulations apply to the client base they intend to serve. A collector whose primary clients are trucking companies operates primarily under FMCSA 49 CFR Part 382 and Part 40. A collector serving aviation employers must also understand FAA-specific requirements. Understanding this regulatory landscape before training ensures that the practitioner is learning the rules applicable to their specific market.
Step 2: Complete DOT Collector Qualification Training
49 CFR Part 40, Subpart C establishes the qualification requirements for urine specimen collectors. Collector qualification requires completion of all of the following components, in order:
-
Qualification training — formal instruction covering all collector requirements under Part 40, collection procedures, use and completion of the CCF, fatal flaw identification, and shy bladder protocol. Training may be completed through a qualified training provider, including online courses that meet Part 40 standards.
-
Successful completion of five mock collections — the trainee must demonstrate proficiency by successfully completing five mock collection scenarios, including at minimum one observed and one directly observed collection. Mock collections must be conducted under the observation of a qualified trainer.
-
Qualification by a currently qualified collector — the trainee must be observed completing and successfully passing all steps of a collection procedure without errors or omissions by a currently qualified collector who can attest to the trainee's proficiency.
Training that does not satisfy all three components does not meet the Part 40 qualification standard. Error correction training is required if a collector makes a fatal flaw or a correctable flaw during qualification — the error correction training must focus specifically on the error type and must include additional supervised mock collections.
Step 3: Complete Breath Alcohol Technician (BAT) Training
Collectors who intend to conduct DOT alcohol testing must complete separate training and qualification as a Breath Alcohol Technician. BAT training under Part 40 Subpart J covers the use of Evidential Breath Testing (EBT) devices, the two-step testing process (initial screening followed by confirmation on a separate device or a 15-minute waiting period), and documentation requirements specific to alcohol testing.
BAT qualification requires demonstrated proficiency with the specific EBT device the BAT will use in practice — qualification on one device does not automatically qualify the BAT on a different device. Screening Test Technicians (STTs), who use non-evidential screening devices, have a separate, less extensive qualification requirement and are limited to the screening (not confirmation) portion of the testing process.
Step 4: Pass Proficiency Demonstrations
Collector qualification under Part 40 requires demonstrated proficiency in specific collection types:
- Standard (non-observed) collections — the most common collection type, used when there is no specific basis for direct observation
- Observed collections — required when the collector has reason to believe the donor may attempt to adulterate or substitute the specimen, or when the laboratory reports a specimen as invalid, substituted, or adulterated in a prior test
- Shy bladder protocol — the standardized procedure followed when a donor cannot provide an adequate specimen volume (45 mL) within the initial two-hour waiting period
Each of these scenarios involves distinct procedural requirements under Part 40, and collectors must be prepared to execute them accurately. Observed collections in particular involve specific same-gender requirements and documentation that must be handled precisely.
Step 5: Obtain Professional Certification
While professional certification is not explicitly required by 49 CFR Part 40, industry-recognized credentials from established organizations are increasingly expected by C/TPAs, employer clients, and collection service networks. Two primary credentialing bodies serve the drug testing industry:
DATIA (Drug and Alcohol Testing Industry Association) offers the Certified Professional Collector Technician (CPCT™) designation. This credential verifies that the holder has demonstrated competency in collection procedures, Part 40 requirements, CCF completion, and chain of custody protocols. DATIA also offers broader industry credentials at more advanced levels.
NDASA (National Drug & Alcohol Screening Association) provides training programs and professional credentials for drug testing professionals, with an emphasis on professional standards, continuing education, and industry compliance.
Certification through either body signals to clients and C/TPAs that the practitioner operates to a professional standard — a meaningful differentiator in a field where unqualified collection can produce unchallenged results or legally vulnerable documentation.
Step 6: Register with a Consortium/Third-Party Administrator (C/TPA)
A Consortium/Third-Party Administrator (C/TPA) is an organization that provides drug and alcohol testing program management services to employers — including maintaining random testing pools, selecting employees for random testing, maintaining required records, and providing collector network services. Many DOT-regulated employers, particularly small motor carriers that cannot maintain a full in-house testing program, use C/TPAs to manage their compliance obligations.
For a mobile collector, registration with one or more C/TPAs is a primary route to client access. C/TPAs maintain approved collector networks and dispatch collection requests to qualified collectors in their network. Registration typically requires documentation of collector qualification, current professional certification, and insurance coverage. Understanding the C/TPA relationship — including fee structures, collection documentation requirements, and reporting timelines — is essential to operating effectively within the industry.
Step 7: Establish Business Licenses and Operational Requirements
The operational infrastructure for a mobile drug testing business includes several compliance-specific components:
- Business entity and licensing — standard business formation (LLC is typical) and any state or local business licenses required
- HIPAA considerations — drug test results are protected health information under some interpretations, and collectors handling medical information should understand applicable privacy requirements and use appropriate confidentiality agreements with employer clients
- Specimen handling protocols — specimens must be maintained at appropriate temperatures between collection and shipment; temperature strips on collection cups provide the initial temperature validation (90–100°F), and specimens must be shipped to the laboratory using approved shipping containers that maintain integrity
- Chain of custody log — mobile collectors must maintain a log of all specimens collected, documenting chain of custody from collection through laboratory receipt
- Collection supply inventory — DOT-regulated collections require federally approved collection cups or split-specimen collection kits; collectors are responsible for maintaining an adequate supply of approved materials
- Laboratory accounts — a registered account with one or more SAMHSA-certified laboratories is required to ship and receive results for DOT-regulated collections
Step 8: Build a Client Base
The mobile drug testing business model depends on employer clients who require ongoing testing services. Primary target client categories include:
- DOT-regulated motor carriers — commercial trucking companies of all sizes are legally required to maintain random testing programs year-round; the FMCSA 49 CFR Part 382 random testing rate is 50% for drugs and 10% for alcohol annually, generating consistent collection volume
- Construction and general contractors — many construction companies maintain drug-free workplace programs as a condition of surety bonding, insurance coverage, or contract requirements
- Healthcare facilities — hospitals, clinics, and long-term care facilities maintain both pre-employment and ongoing testing programs for clinical and direct-care staff
- Staffing firms and HR companies — staffing agencies that place workers in regulated industries are a scalable client source with high collection volume per account
Certification Options
DATIA CPCT™
The Drug and Alcohol Testing Industry Association's Certified Professional Collector Technician (CPCT™) is a nationally recognized credential for urine specimen collectors. The examination covers collection procedures, Part 40 requirements, CCF completion, chain of custody, shy bladder protocol, and error identification. DATIA credentials require periodic renewal and continuing education as a condition of maintaining the designation. DATIA also serves as an industry resource for regulatory updates, training programs, and professional networking.
NDASA Credentials
The National Drug & Alcohol Screening Association offers professional credentials and training programs aligned with current Part 40 standards. NDASA provides curriculum for collectors and BATs, and its credentials are recognized by major C/TPAs and collection networks. NDASA also offers continuing education resources for practitioners maintaining qualification in an evolving regulatory environment.
C/TPA-Sponsored Training
Many C/TPAs offer or require their own training programs for collectors joining their networks. These programs typically build on Part 40 qualification training with additional instruction on the C/TPA's documentation systems, reporting protocols, and quality standards. C/TPA-sponsored training does not substitute for Part 40 qualification but complements it.
DOT Qualification Training Requirements
Under 49 CFR Part 40, Subpart C, the qualification training requirement does not specify a particular provider or credential — it specifies a content standard and a demonstration standard. Any training that covers all required collector procedures under Part 40 and that includes the required mock collections may satisfy the qualification standard. ODAPC publishes guidance on what constitutes acceptable qualification training, and practitioners should verify that their training provider's program meets current ODAPC standards.
What Does a Mobile Drug Testing Professional Do Day-to-Day?
A mobile drug testing professional begins each workday managing their collection schedule — a combination of scheduled employer appointments and on-call dispatches from C/TPA clients. Pre-employment and random testing appointments are typically scheduled in advance; reasonable suspicion and post-accident collections may require same-day response.
At each employer location, the collector establishes a temporary collection site that meets the privacy and integrity requirements of 49 CFR Part 40, Subpart E. This includes a designated collection area with appropriate privacy for the donor, a source of water for handwashing, and secure handling of collection materials. Temporary collection sites must comply with the same fundamental requirements as fixed facilities.
The collector identifies and explains the collection process to each donor — including the donor's requirement to remove outer garments, leave personal belongings outside the collection area, and cooperate with the collection procedure. For observed collections, the collector must have the specific regulatory basis for observation documented.
Throughout the collection, the collector completes the CCF in full — recording specimen identification numbers, temperature reading, remarks regarding any irregularities, and executing the required collector certification. For split specimen collections (required for all DOT urine collections), both the primary (Bottle A) and split (Bottle B) specimens must be sealed with tamper-evident seals in the donor's presence, with the donor initialing the seals.
Specimens are secured for transport to the laboratory, typically through a collection courier service or overnight shipping. The collector's copy of the CCF is retained for the collector's records, and copies are forwarded as required to the MRO and employer.
Income and Business Potential
Per-collection fees for mobile collectors vary by testing type, client type, and geographic market. DOT-regulated collections typically range from $35 to $75 per collection, with non-DOT employer contract pricing varying based on volume commitments and service level agreements. Mobile collectors generally command a premium over fixed-site rates because the service eliminates the employer's need to send employees offsite for testing — a significant operational benefit for employers with large or distributed workforces.
Revenue models in this field typically take two forms: per-test contract pricing for individual or occasional collection requests, and monthly retainer arrangements for employer accounts with consistent ongoing volume. Retainer accounts — particularly motor carriers with DOT random testing programs — provide predictable annual revenue because the random testing requirement is year-round, not seasonal.
Volume potential is meaningful for collectors serving DOT-regulated clients. A motor carrier with 50 covered drivers under FMCSA's 50% annual random rate generates approximately 25 drug test collections per year — a steady, predictable volume from a single account.
Scaling a mobile drug testing practice typically follows one of several paths: adding BAT certification to offer the full DOT testing menu, developing MRO support relationships that create documentation workflow opportunities, or partnering with HR consulting firms and occupational health companies that serve employer clients needing comprehensive testing program management.
How SecureServe Academy™ Prepares You
SecureServe Academy™ offers structured professional preparation for the Mobile Drug Testing Professional career path through the Justice & Compliance Services™ division. The curriculum is designed to meet DOT-standard requirements — compliance-first, regulation-grounded, and built for practitioners who want to enter this field with the knowledge necessary to perform collections accurately and operate a practice professionally.
The Mobile Drug Testing Professional program covers the regulatory framework in depth, from 49 CFR Part 40 collection procedures through CCF completion, chain of custody documentation, temporary collection site requirements, and C/TPA integration. Instruction is structured to prepare candidates for collector qualification under Part 40 and for the professional certification examinations offered by DATIA and NDASA.
SecureServe Academy™ does not guarantee employment, income outcomes, or client acquisition results. The program is professional education — it prepares practitioners with the regulatory knowledge and procedural competency to enter the field and operate compliantly. What practitioners do with that foundation is a function of their own professional effort and business development.
A credential verification system supports practitioners in documenting their preparation for C/TPA registration and employer client vetting processes.
Conclusion
Mobile drug testing is a federally regulated profession with specific qualification requirements, detailed procedural standards, and ongoing compliance obligations. Entry into this field requires more than a basic course — it requires demonstrating procedural proficiency, obtaining appropriate credentials, establishing operational infrastructure, and integrating with the C/TPA and laboratory networks that form the backbone of the industry.
Certification through DATIA or NDASA, combined with proper Part 40 qualification training and demonstrated collection proficiency, provides the professional foundation a mobile collector needs to be taken seriously by employer clients, accepted into C/TPA networks, and trusted to produce legally defensible chain of custody documentation.
For professionals ready to pursue a compliant, credential-based mobile drug testing practice, SecureServe Academy™ provides the institutional preparation to enter this field correctly.
Explore Mobile Drug Testing Professional certification programs at SecureServe Academy™ →
Ready to Get Certified?
Enroll in the Mobile Drug Testing Professional Certification Program™ and earn a verifiable professional credential.